$UNH

Healthcare surged in June. Raymond James is adding these two dividend payers to list of top picks

Healthcare rose more than 6% in June as investors favored defensives over tech. Raymond James refreshed its healthcare top-picks list, adding UnitedHealth Group (UNH) and Janus Living (JAN). UNH is up 28% YTD; Q1 adjusted EPS $7.23 on $111.72B revenue; raised dividend to $2.32. JAN, an REIT, debuted in March IPO at $20 and closed at $28.99; dividend yield 1.96%.

Original reporting
Published Jul 2, 2026, 8:30 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 2, 2026, 8:41 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Healthcare surged in June. Raymond James is adding these two dividend payers to list of top picks — source image
Decision brief

The 30-second read

$UNHBullishLow
01

Why it matters

The actionable element is the analyst-driven catalyst framing: UNH is tied to an upcoming earnings date and margin/cost moderation thesis; JAN is tied to improving occupancy/margins and acquisition sourcing in seniors housing.

02

Market read

This is a buy-list refresh during a defensive rotation; it may influence short-term positioning but lacks new company-specific disclosures beyond previously referenced results and a dividend hike.

03

What to watch

For UNH, the article cites moderating cost trends but provides no new datapoint beyond prior quarter results; for JAN, the piece doesn’t quantify acquisition pipeline or occupancy trajectory, leaving execution risk.

Relevance 4/10Novelty 4/10Timing: into the July 16 UNH earnings window; post-list refresh for JAN

Background

Healthcare outperformed in June (+6% per the article) as investors rotated away from software and mega-cap tech; Raymond James refreshed its top picks with dividend payers.

Company-level read

Ticker impact

$UNHBullishMedium confidence
Context

Raymond James added UnitedHealth to its top healthcare picks, citing near-term upside around the July 16 earnings report and improving margins.

Expected impact

Moderate upside bias into the July 16 earnings window; limited impact beyond sentiment unless earnings confirm margin/cost moderation.

Evidence & confidence

The article is an analyst note update (not a new earnings print), but it includes concrete guidance context (prior quarter beat, raised full-year EPS, dividend hike) and a dated upcoming earnings catalyst.

$JANBullishMedium confidence
Context

Raymond James recommended Janus Living as a top pick, pointing to improving seniors housing fundamentals and acquisition sourcing in a fragmented market.

Expected impact

Potential near-term support from buy-list momentum; upside likely capped unless fundamentals or acquisition pipeline accelerates.

Evidence & confidence

This is primarily a promotional/strategy update, but it contains specific fundamental drivers and notes the IPO timing and current dividend yield, which can matter for positioning.

Market effects

Reinforces a defensive rotation into healthcare and dividend payers after tech weakness; may support relative performance of managed care and seniors housing.

Primarily US equity flows; no explicit cross-region catalyst beyond sector rotation.

Limited—framed as US healthcare positioning and cost-trend/margin dynamics.

Counterpoint

Top-pick additions can lag fundamentals; if medical cost trends re-accelerate or occupancy recovery stalls, the thesis could unwind despite the endorsement.

Key entities

  • UnitedHealth Group

    Added to Raymond James’ top healthcare picks; thesis centers on July 16 earnings upside, moderating medical costs, improving insurance/Optum margins, and a recent dividend increase.

  • Janus Living

    Added as a top pick; thesis centers on improving seniors housing fundamentals (occupancy, limited new supply, demographics) and acquisition sourcing in a fragmented market.

  • Raymond James

    Investment bank refreshing its top healthcare picks list with two dividend-paying stocks.

Related articles

$MSFTLow

Microsoft, Google, and Goldman Just Said No To Tokenized Shares

Microsoft, Alphabet, Goldman Sachs, and 13 other companies have objected to trading tokenized versions of their shares on OKXICE, a 24/7 crypto venue. The SEC's new rule allows such trading, but the companies' concerns include price drift and reputational risks. OKXICE plans to trade tokens for 62 companies, with 16 objecting so far. The objection list is dominated by AI and tech firms, which are particularly sensitive to price volatility and news-driven swings.

$UNHMed

UnitedHealthcare and Humana cut Medicare Advantage plans for 1 mn

UnitedHealthcare and Humana are discontinuing Medicare Advantage plans covering nearly 1 million members, withdrawing from less profitable markets. UnitedHealthcare is ending plans for 390,000 members, while Humana is cutting 600,000. Both companies are focusing on more profitable products and regions, according to reports. Rising medical costs are driving these changes, with insurers reducing flexible PPO plans and increasing out-of-pocket expenses for members.

$SMCIHigh

Wall Street Futures Rise as Corporate Earnings Support Technology Stocks: Dow Jones, S&P, Nasdaq

US stock index futures rose on Wednesday, with tech stocks expected to lead gains. SpaceX (SPCX) shares surged 8.8% after beating earnings estimates, while Super Micro Computer (SMCI) gained 12.2% on raised revenue outlook. Netflix (NFLX) fell 6.8% and AT&T (T) dropped 5% despite strong earnings. Investors await results from Tesla (TSLA), Meta (META), and IBM (IBM). Dow, S&P 500, and Nasdaq showed mixed performance on Tuesday.

$UNHMed

UnitedHealth Sees Commercial Plan Cost Increases Rising Over 11%

UnitedHealth Group reported Q3 net income of $4.3B on $112.7B revenue, with commercial health coverage revenue up 0.9%. CEO Tim Noel noted higher-than-expected medical cost increases, citing specialty drugs, clinician costs, and the No Surprises Act. Enrollment fell 3.6% YoY, with Medicare and Medicaid plans seeing significant declines. Despite rising costs, sales for large employer plans remain strong, according to new CEO Brandon Cuevas.